Expanded subsets of circulating CD38+T cells in B cell chronic lymphocytic leukemia [B-CLL]

被引：0
|
作者：
Bjork, RL
Mcdaniel, PR
Saven, A
Bjork, RL
机构：
[1] BioTelesis Corp, San Diego, CA USA
[2] Esoterix Oncol, San Diego, CA USA
[3] Scripps Res Inst, La Jolla, CA USA
来源：
CYTOMETRY | 2002年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [31] CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) LYMPHOCYTE - B OR T CELL
    SAGONE, AL
    BALCERZA.SP
    HURTUBIS.P
    LOBUGLIO, AF
    MURPHY, S
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 40 (06): : 960 - &
  • [32] Perforin and serine esterase-expressing circulating CD4+cells are present in patients with B-chronic lymphocytic leukemia (B-CLL).
    Porakishvili, N
    Roschupkina, T
    Jewell, AP
    Patterson, K
    Yong, K
    Lydyard, PM
    BLOOD, 1999, 94 (10) : 437A - 437A
  • [33] Cytokine gene expression in a case of B-cell chronic lymphocytic leukemia (B-CLL) with an unusual expansion of T cells at presentation
    Mouzaki, A
    Kindler, V
    Bowers, N
    Doucet, A
    Melachrinou, M
    Kyrtsonis, MC
    KallinikouManiatis, A
    MOLECULAR BIOLOGY OF HEMATOPOIESIS 5, 1996, : 237 - 246
  • [34] Gene expression profiling of peripheral blood T cells in patients with indolent B-cell chronic lymphocytic leukemia (B-CLL)
    Kiaii, K.
    Osterborg, A.
    Mashayekhi, K.
    Moshfegh, A.
    Choudhury, A.
    Mellstedt, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 33 - 33
  • [35] VH analysis in familial chronic lymphocytic leukemia (B-CLL).
    Siakantaris, MP
    Kontopidou, FN
    Kyrtsonis, MC
    Vassilakopoulos, TP
    Kokoris, SI
    Dimopoulou, MN
    Dimitriadou, EM
    Angelopoulou, MK
    Pangalis, GA
    BLOOD, 2003, 102 (11) : 670A - 670A
  • [36] CD5 POSITIVE AND NEGATIVE B-CLL - EVIDENCE SUPPORTING PHENOTYPIC HETEROGENEITY IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    FAGUET, GB
    MARTI, GE
    AGEE, JF
    BERTIN, P
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 651 : 470 - 474
  • [37] Reconstitution of the T cell repertoire following treatment with alemtuzumab in patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Rezvany, MR
    Tehrani, MJ
    Karlsson, C
    Lundin, J
    Rabbani, H
    Mellstedt, K
    Österborg, A
    BLOOD, 2005, 106 (11) : 837A - 837A
  • [38] High CD79b Expression Predicts a Poor Outcome in B-Cell Chronic Lymphocytic Leukemia (B-CLL).
    Del Poeta, Giovanni
    Del Principe, Maria Ilaria
    Zucchetto, Antonella
    Buccisano, Francesco
    Simotti, Cristina
    Maurillo, Luca
    Gianni, Laura
    Bulian, Pietro
    Venditti, Adriano
    Coletta, Angela
    Niscola, Pasquale
    de Fabritiis, Paolo
    Gattei, Valter
    Amadori, Sergio
    BLOOD, 2008, 112 (11) : 386 - 386
  • [39] Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance
    Tania Calvo
    Chantal Reina-Ortiz
    David Giraldos
    María Gascón
    Daniel Woods
    Judit Asenjo
    Joaquín Marco-Brualla
    Gemma Azaceta
    Isabel Izquierdo
    Luis Palomera
    Diego Sánchez-Martínez
    Isabel Marzo
    Javier Naval
    Carlos Vilches
    Martín Villalba
    Alberto Anel
    Scientific Reports, 10
  • [40] Blood "nurse-like" cells of patients with B cell chronic lymphocytic leukemia (B-CLL) prevent in vitro apoptosis of CLL B cells.
    Burger, JA
    Kipps, TJ
    BLOOD, 1999, 94 (10) : 633A - 633A
12345